Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Double-blind Treatment

Effect of Trunk Stabilization Exercises on Quality of Life and Communication in Cerebral Palsy

Cerebral Palsy

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
May 2020
Primary outcome: Primary: Visual Analogue Scale (VAS) — 6.75; 5.29 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Neurodevelopmental treatment (NDT) (Other); Feeding and oral-motor intervention strategies (Other); Neck and trunk stabilization exercises (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Marmara University
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Analogue Scale (VAS)
6.75; 5.29
PRIMARY
Katz Index of Independence in Activities of Daily Living (ADL)
0.70; 0.55
PRIMARY
Pediatric Quality of Life Inventory (PedsQL). Version 4.0- Parent Report for Toddlers (Ages 2-4)
48.42; 53.48
PRIMARY
Short Form 36 Questionnaire (SF-36)
80.25; 81.75
PRIMARY
Viking Speech Scale (VSS)
3.14; 3.50
PRIMARY
Gross Motor Function Classification System (GMFCS)
4; 2; 0; 0; 2; 0
PRIMARY
Communication Function Classification System (CFCS)
1; 1; 4; 3; 8; 2

Summary

To investigate the effectiveness of neck and trunk stabilization exercises on communication and quality of life (QoL) in children with cerebral palsy (CP) with oral motor problems. Children with CP were randomly divided into Study Group (SG) and Control Group (CG). Neurodevelopmental treatment (NDT) approaches and oral motor therapy were applied to both groups. SG also received neck-trunk stabilization training.

Eligibility Criteria

Inclusion Criteria

  • 1.5 years and older,
  • Lack of cooperation problem to prevent communication,
  • To have been diagnosed with cerebral palsy and admitted to the hospital for routine control,
  • Volunteer to participate in the research,
  • Existence of at least one of the items of the "Key Questions" interrogation system showing feeding/swallowing problems in children with cerebral palsy.

Exclusion Criteria

  • Presence of severe vision and hearing loss,
  • Use any pharmacological agent to inhibit spasticity,
  • He/she had undergone orthopedic surgery or Botulinum Toxin-A injection in the last six months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04214080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search